Pharma Sources Insight January 2021: Rolling Out the Vaccines

How to subscribe?

Pharma Sources Insight January 2021 focuses on the following topics:

PHARMA IN CHINA

- Analysis of the Regulatory Inspection Trends of China, the U.S. and the EU in the Pandemic Year and Outlook Therefor

- Biosimilars 2020: Low Approvals, but Significant Advances

- Chinese-produced Anticancer Drugs Granted Designations by the FDA in 2020

- A Brief Preview of 2021 in the Pharmaceutical Industry

COVID-19

- A Brief Overview of COVID-19 Pandemic in 2020

- Chinese Vaccines Going Global amid Receipt of the COVID-19 Vaccines Worldwide

- Notable Vaccines Against COVID-19 Making Promising Progress

- Rolling Out the Vaccines

Brand Story

- Sterile Solvent Crystallization API Systems

Industry Insight

- Advancing Oncology

Click on the link or Scan the QR code to read the Pharma Sources Insight (January 2021):

About Pharma Sources Insight

Pharma Sources Insight is a unique source of updated coverages on current events and deep insights into hot areas of the pharma industry, from China to the world. It follows up new developments with those among the leading drug-manufacturers in China which further affect the world. 

Now, join PharmaSources.com to get access to news of the Chinese pharmaceutical enterprises and to witness industrial changes through the exclusive perspectives of our expert writers into crucial aspects of the pharmaceutical field, all under PharmaSources.com and CPhI China.